Osaic Holdings’s CervoMed CRVO Stock Holding History

Osaic Holdings’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$118	Sell	30 -378	-93%	-$1.97K	﹤0.01%	7614
2025 Q4	$3.22K	Buy	408 +378	+1,260%	+$3.04K	﹤0.01%	6919
2025 Q3	$268	Hold	30	–	–	﹤0.01%	7659
2025 Q2	$187	Buy	30 +13	+76%	+$111	﹤0.01%	7513
2025 Q1	$154	Sell	17 -378	-96%	-$1.44K	﹤0.01%	7197
2024 Q4	$924	Hold	395	–	–	﹤0.01%	6867
2024 Q3	$5.77K	Hold	395	–	–	﹤0.01%	6128
2024 Q2	$6.76K	Hold	395	–	–	﹤0.01%	6020
2024 Q1	$9.2K	Hold	395	–	–	﹤0.01%	5791
2023 Q4	$3.83K	Hold	395	–	–	﹤0.01%	6269
2023 Q3	$1.82K	Sell	395 -1	-0.3%	-$5	﹤0.01%	6662
2023 Q2	$1.98K	Sell	396 -13	-3%	-$76	﹤0.01%	6666
2023 Q1	$2.55K	Buy	409 +9	+2%	+$80	﹤0.01%	6610
2022 Q4	$3K	Hold	400	–	–	﹤0.01%	6488
2022 Q3	$3K	Hold	400	–	–	﹤0.01%	6599
2022 Q2	$4K	Sell	400 -1	-0.2%	-$12	﹤0.01%	6573
2022 Q1	$7K	Buy	401 +5	+1%	+$99	﹤0.01%	6313
2021 Q4	$9K	Buy	396 +2	+0.5%	+$63	﹤0.01%	6324
2021 Q3	$16K	Hold	394	–	–	﹤0.01%	5912
2021 Q2	$22K	Buy	394 +1	+0.3%	+$55	﹤0.01%	5595
2021 Q1	$27K	Hold	393	–	–	﹤0.01%	5292
2020 Q4	$24K	Sell	393 -35	-8%	-$2.05K	﹤0.01%	5038
2020 Q3	$27K	Buy	428 +404	+1,683%	+$30.7K	﹤0.01%	4722
2020 Q2	$2K	Hold	24	–	–	﹤0.01%	5766
2020 Q1	$0	Buy	+24	New	+$728	﹤0.01%	6080

Other funds holding CRVO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

CFG

Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Osaic Holdings's CRVO Position: Q1 2026 in Review

Osaic Holdings reduced its CervoMed (CRVO) stake by 93% in Q1 2026, selling an estimated $1.97K and leaving 30 shares worth $118. The position accounts for ﹤0.01% of the portfolio, ranked #7614.

Osaic Holdings first reported a position in CRVO in Q1 2020 and has held it in 25 quarters since. The position peaked at $27K in Q1 2021. 36 funds tracked by Wall St. Rank hold CRVO as of Q1 2026.

Osaic Holdings held 30 shares of CervoMed worth $118 as of Q1 2026.
Osaic Holdings sold 378 CervoMed shares in Q1 2026, an estimated $1.97K.
CervoMed made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7614 holding.
Osaic Holdings first reported a position in CervoMed in Q1 2020 and has held it in 25 quarters since.
Osaic Holdings's CervoMed position peaked at $27K in Q1 2021.
36 funds tracked by Wall St. Rank held CervoMed as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.